文献速递临床试验与 GCP

急性胆囊炎治疗中围手术期抗生素预防(PEANUTS II试验):随机对照试验研究方案

Perioperative antibiotic prophylaxis in the treatment of acute cholecystitis (PEANUTS II trial): study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2017-08-23

PEANUTS II试验为随机、对照、多中心、开放标签非劣效性试验,旨在确定急性结石性胆囊炎急诊胆囊切除术患者术前抗生素预防的价值。按东京指南定义为轻或中度急性胆囊炎的患者随机接受单次术前抗生素预防(2000 mg第一代头孢菌素静脉给药)或不接受抗生素预防。主要终点为术后30天内所有术后感染性并发症的复合终点,假设无抗生素预防非劣效于有抗生素预防,非劣效界值10%,单侧风险2.5%、把握度80%,需纳入454例受试者,按意向性治疗原则分析。

要点

  • PEANUTS II试验比较急性结石性胆囊炎急诊胆囊切除术术前单次抗生素预防与无抗生素预防。
  • 主要终点为术后30天内所有术后感染性并发症的复合终点,非劣效界值10%。
  • 计划纳入454例轻或中度急性胆囊炎患者,按意向性治疗原则分析。

核心结论

  • PEANUTS II试验将为急性结石性胆囊炎急诊胆囊切除术患者使用抗生素预防提供循证建议。

研究设计与样本

  • 随机、对照、多中心、开放标签非劣效性试验,计划纳入454例受试者。
  • 研究对象为按东京指南定义为轻或中度急性结石性胆囊炎的急诊胆囊切除术患者。
  • 受试者随机接受单次术前抗生素预防(2000 mg第一代头孢菌素静脉给药)或不接受抗生素预防。
  • 主要终点为术后30天内所有术后感染性并发症的复合终点。
  • 按意向性治疗原则分析,假设无抗生素预防非劣效于有抗生素预防,非劣效界值10%,单侧风险2.5%、把握度80%。

关键数值与推荐

  • 非劣效界值设定为10%。
  • 单侧风险2.5%、把握度80%,计划纳入454例受试者。
  • 术前抗生素预防方案为单次2000 mg第一代头孢菌素静脉给药。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The additional value of perioperative antibiotic prophylaxis in preventing infectious complications after emergency cholecystectomy for acute cholecystitis is a much-debated subject in the surgical community. Evidence-based guidelines are lacking, and consequently the use of antibiotic prophylaxis varies greatly among surgeons and hospitals. Recently, high-level evidence became available demonstrating that postoperative antibiotic prophylaxis in patients with acute cholecystitis does not reduce the risk of infectious complications. Preoperative antibiotic prophylaxis in relation to the risk of infectious complications, however, has never been studied. METHODS: The PEANUTS II trial is a randomized, controlled, multicenter, open-label noninferiority trial whose aim is to determine the utility of preoperative antibiotic prophylaxis in patients undergoing emergency cholecystectomy for acute calculous cholecystitis. Patients with mild or moderate acute cholecystitis, as defined according the Tokyo Guidelines, will be randomly assigned to a single preoperative dose of antibiotic prophylaxis (2000 mg of first-generation cephalosporin delivered intravenously) or no antibiotic prophylaxis before emergency cholecystectomy. The primary endpoint is a composite endpoint consisting of all postoperative infectious complications occurring during the first 30 days after surgery. Secondary endpoints include all the individual components of the primary endpoint, all other complications, duration of hospital stay, and total costs. The hypothesis is that the absence of antibiotic prophylaxis is noninferior to the presence of antibiotic prophylaxis. A noninferiority margin of 10% is assumed. With a 1-sided risk of 2.5% and a power of 80%, a total of 454 subjects will have to be included. Analysis will be performed according to the intention-to-treat principle. DISCUSSION: The PEANUTS II trial will provide evidence-based advice concerning the utility of antibiotic prophylaxis in patients undergoing emergency cholecystectomy for acute calculous cholecystitis. TRIAL REGISTRATION: Netherlands Trial Register, NTR5802 . Registered on 4 June 2016.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Loozen CS, van Santvoort HC, van Geloven AAW, et al. Perioperative antibiotic prophylaxis in the treatment of acute cholecystitis (PEANUTS II trial): study protocol for a randomized controlled trial. Trials. 2017. PMID: 28835268. doi:10.1186/s13063-017-2142-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。